Navigation Links
Collaborative Innovation Between CDISC and IMI Facilitates Development of Global Standards
Date:6/11/2013

Austin, TX (PRWEB) June 12, 2013

CDISC has long proven itself to be a catalyst for collaborative innovation, as evidenced through the many opportunities it has created for partners and stakeholders to streamline the medical research processes. Recent releases of CDISC consensus-based data standards for tuberculosis, Alzheimer’s disease, Parkinson’s disease, pain and polycystic kidney disease are examples.

In 2011, the Innovative Medicines Initiative (IMI) and the Clinical Data Interchange Standards Consortium (CDISC) signed a Memorandum of Understanding to outline the collaboration between the two organizations. It was agreed that common data standards and formats are necessary to effectively pool, manage and analyze information both within and across IMI projects. In 2012, through the CDISC Europe Foundation (CEF), CDISC became a partner on three IMI project consortia: EHR4CR, BioVacSafe, and most recently eTRIKS.    Additional IMI consortia are using CDISC standards, and CDISC is providing education and training as well as data standards expertise to assist in integration of both prospective and retrospective clinical research data.

IMI Executive Director Professor Michel Goldman commented: “IMI is committed to collaborating with partners like CDISC to share data, ideas and experience to avoid the duplication of effort. Only by working together in this way can we hope to speed up the development of new treatments to tackle deadly and debilitating diseases."

Looking forward, CDISC is co-leading the data standards work package for eTRIKS with Roche and IDBS. Building upon the open source tranSMART system, eTRIKS aims to 1) enable data integration, 2) build a common set of standards, 3) increase operational efficiency and 4) ensure the legacy of translational research data generated in IMI and other European projects focused on therapeutic areas such as severe asthma, rheumatoid arthritis, depression and schizophrenia, multiple sclerosis, tuberculosis and several types of cancer. This aligns well with the ongoing and planned development of new CDISC Therapeutic Area Standards, including schizophrenia, oncology, asthma and diabetes.

CDISC also continues to develop standards in the therapeutic areas through the tremendous support of its many members and volunteers, as well as collaborating entities such as TransCelerate Biopharma and the U.S. Food and Drug Administration (FDA). The CDISC consensus-based standards development process encourages collaboration amongst these diverse companies and organizations, thus resulting in true global standards. “CDISC’s collaboration with IMI and participation in key IMI projects creates a great opportunity to align Therapeutic Area Standards projects and priorities among IMI, TransCelerate Biopharma, FDA, global biopharmaceutical companies, patient foundations and others. This sets the stage to ensure therapeutic area standards development is well synchronized globally,” stated Mr. Kisler, CDISC VP, Strategic Alliances.

ABOUT CDISC
CDISC is a 501(c)(3) global non-profit charitable organization, with over 300 supporting member organizations from across the clinical research and healthcare arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can significantly decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning healthcare system. The CDISC Vision is to inform patient care and safety through higher quality medical research.
_________________________________________

Electronic Health Records for Clinical Research: http://www.ehr4cr.eu
Biomarkers for Enhanced Vaccine Immunosafety: http://biovacsafe.eu
European Translational Research Information & Knowledge Management Services: http://www.etriks.org

Read the full story at http://www.prweb.com/releases/2013/6/prweb10825053.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DFG establishes 20 new Collaborative Research Centres
2. High value health care collaborative receives $26 million health care innovation grant
3. Recruiting for Good Launches Pet Philanthropy Program to Collaboratively Fundraise for Kitt Crusaders an Animal Rescue Organization
4. Regenstrief and IHTSDO start collaborative efforts
5. UC San Diego, Yale awarded collaborative NSF grant for Neuroscience Gateway
6. From textbook to flexbook: Professor uses new collaborative tool in the classroom
7. Gabrielles Angel Foundation for Cancer Research announces 2 collaborative research grants
8. DFG funds new Collaborative Research Center at the Mainz University Medical Center
9. Global collaborative efforts help delineate pediatric TBI in China
10. NIH launches collaborative effort to find biomarkers for Parkinsons
11. Three Dentists Awarded Master Dental Sleep Physician Designation at Elite Dental Institute’s Annual Collaborative Sleep Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
Breaking Medicine Technology: